TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Novo Nordisk Scandinavia AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,817,185
|
1,103,660
|
913,239 |
Financial expenses |
406
|
81
|
117 |
Earnings before taxes |
72,424
|
48,411
|
28,055 |
EBITDA |
67,397
|
47,289
|
28,266 |
Total assets |
493,935
|
423,202
|
382,527 |
Current assets |
493,674
|
422,854
|
382,062 |
Current liabilities |
323,974
|
288,191
|
280,443 |
Equity capital |
129,001
|
94,202
|
68,328 |
- share capital |
101
|
95
|
98 |
Employees (average) |
110
|
115
|
106 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
26.1%
|
22.3%
|
17.9% |
Turnover per employee |
16,520
|
9,597
|
8,615 |
Profit as a percentage of turnover |
4.0%
|
4.4%
|
3.1% |
Return on assets (ROA) |
14.7%
|
11.5%
|
7.4% |
Current ratio |
152.4%
|
146.7%
|
136.2% |
Return on equity (ROE) |
56.1%
|
51.4%
|
41.1% |
Change turnover |
635,213
|
217,867
|
-31,303 |
Change turnover % |
54%
|
25%
|
-3% |
Chg. No. of employees |
-5
|
9
|
11 |
Chg. No. of employees % |
-4%
|
8%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.